q buffer diluent (Gator Bio Inc)
Gator Bio Inc is a verified supplier 
Gator Bio Inc manufactures this product 
94
Structured Review
Gator Bio Inc
q buffer diluent
Q Buffer Diluent, supplied by Gator Bio Inc, used in various techniques. Bioz Stars score: 94/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/q+buffer+diluent/Q+Buffer/10__1172_slash_jci199277-317-36-38
Average 94 stars, based on 13 article reviews
Q Buffer Diluent, supplied by Gator Bio Inc, used in various techniques. Bioz Stars score: 94/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/q+buffer+diluent/Q+Buffer/10__1172_slash_jci199277-317-36-38
Average 94 stars, based on 13 article reviews
q buffer diluent - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Incubation:Article Title: A Trypanosoma cruzi Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin America Article Snippet: .. The final method consisted of the following BLI conditions: 1) 600 second (s) incubation of anti-His probe in 2ug/mL peptide antigen, 2) 1800s incubation in 10uL of plasma diluted 1:19 with Article Title: A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions Article Snippet: .. The final method consisted of the following BLI conditions: (a) 600 second (s) incubation of anti-His probe in 2 μg/mL peptide or multiepitope antigen, (b) 1,800 s incubation in 10 μL of plasma diluted 1:19 with Article Title: A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions Article Snippet: .. The final method 618 consisted of the following BLI conditions: 1) 600 second (s) incubation of anti-His probe in 619 2ug/mL peptide or multiepitope antigen, 2) 1800s incubation in 10uL of plasma diluted 1:19 620 with Clinical Proteomics:Article Title: A Trypanosoma cruzi Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin America Article Snippet: .. The final method consisted of the following BLI conditions: 1) 600 second (s) incubation of anti-His probe in 2ug/mL peptide antigen, 2) 1800s incubation in 10uL of plasma diluted 1:19 with Article Title: A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions Article Snippet: .. The final method consisted of the following BLI conditions: (a) 600 second (s) incubation of anti-His probe in 2 μg/mL peptide or multiepitope antigen, (b) 1,800 s incubation in 10 μL of plasma diluted 1:19 with Article Title: A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions Article Snippet: .. The final method 618 consisted of the following BLI conditions: 1) 600 second (s) incubation of anti-His probe in 619 2ug/mL peptide or multiepitope antigen, 2) 1800s incubation in 10uL of plasma diluted 1:19 620 with |